Luokung Receives NASDAQ Notice Related to Filing of Form 20-F
BEIJING, May 14, 2024 (GLOBE NEWSWIRE) — Luokung Technology Corp. (NASDAQ: LKCO) (“Luokung” or the “Company”), a leading spatial-temporal intelligent […]
CVR Energy Provides Update to Operational Statistics and Financial Information for its Petroleum and Renewables Businesses
SUGAR LAND, Texas, May 14, 2024 (GLOBE NEWSWIRE) — CVR Energy, Inc. (“CVR Energy” or the “Company”) (NYSE: CVI) today […]
Evoke Pharma Reports First Quarter 2024 Financial Results
114% year-over-year increase in net product sales70% prescriber growth in Q1 2024 compared to Q4 2023Growing sales metrics reaffirms company’s […]
CooperCompanies to Participate in the William Blair Growth Stock Conference
SAN RAMON, Calif., May 14, 2024 (GLOBE NEWSWIRE) — CooperCompanies (Nasdaq: COO), a leading global medical device company, will participate […]
Blink Charging Selected as an Official Electric Vehicle Charger and Network Services Provider for State of New York
Blink chosen as one of the EV charging providers designated to provide expanded charging infrastructure and support a more sustainable […]
Stryve Foods, Inc. Reports Fiscal 2024 First Quarter Results
Retail Sales Velocity Increasing +23.2% Year-over-Year1Improved Adj. EBITDA Loss by 35.2% Year-over-Year3Reiterating Net Sales Guidance Range of $24M to $30M […]
NANOBIOTIX Announces US FDA Protocol Acceptance for New Randomized Phase 2 Study Evaluating NBTXR3 for Patients with Stage Three Lung Cancer
PARIS and CAMBRIDGE, Mass., May 14, 2024 (GLOBE NEWSWIRE) — NANOBIOTIX (Euronext: NANO –– NASDAQ: NBTX – the ‘‘Company’’), a […]
Lumos Pharma Announces Positive End-of-Phase 2 Meeting with FDA and Reports First Quarter 2024 Financial Results
Outcome from End-of-Phase 2 Meeting Supportive of a Placebo-Controlled Phase 3 Trial Updated 12 and 24-Month Data from Phase 2 […]
Shattuck Labs to Present Additional Data from the Phase 1B Dose Expansion Clinical Trial of SL-172154 with Azacitidine (AZA) in Frontline Higher-Risk Myelodysplastic Syndromes (HR-MDS) and TP53 mutant (TP53m) Acute Myeloid Leukemia (AML) Patients at the European Hematology Association (EHA) 2024 Congress
– Observed encouraging complete response (CR) rates as of the February 1, 2024, data cutoff in previously untreated HR-MDS and […]
Synaptics Appoints Ken Rizvi as Chief Financial Officer
SAN JOSE, Calif., May 14, 2024 (GLOBE NEWSWIRE) — Synaptics® Incorporated (Nasdaq: SYNA) today announced Ken Rizvi will join the […]
